From October 1, 2023 to December 31, 2023, the company has repurchased 290,582 shares, representing 0.03% for CNY 11.86 million. With this, the company has completed the repurchase of 679,027 shares, representing 0.07% for CNY 26.88 million under the buyback announced on September 10, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
12.62 HKD | -2.77% | -1.56% | -35.08% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-35.08% | 3.62B | |
-2.66% | 88.91B | |
+2.76% | 41.25B | |
-13.92% | 31.99B | |
+50.51% | 24.73B | |
-15.25% | 15.54B | |
-39.93% | 12.07B | |
-9.08% | 12.05B | |
-14.80% | 12.02B | |
+6.22% | 8.84B |
- Stock Market
- Equities
- 1877 Stock
- News Shanghai Junshi Biosciences Co., Ltd.
- Tranche Update on Shanghai Junshi Biosciences Co., Ltd.'s Equity Buyback Plan announced on September 10, 2023.